BioSpace News Archive

Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases, today announced its participation in the following upcoming investor conferences.

Scholar Rock today announced it will present data from its Phase 2 TOPAZ trial extension period evaluating patient outcomes after 24 months of treatment with apitegromab.

Edgewise Therapeutics, Inc. today announced that management will present at the Cowen 43rd Annual Health Care Conference on Wednesday, March 8, 2023, at 9:10 am ET.

Ronovo Surgical invited top gynecology and urology surgeons to evaluate the performance of its newly unveiled Carina™ RAS Platform, the first modular robotic-assisted surgery platform developed in China for laparoscopic procedures.

Tachyon Therapeutics, Inc. today announced the closing of a financing that brings the Company’s total equity financing raises to $11.6 million and, together with a recently announced CIRM grant of $7.1 million, brings total funding in the Company to $18.7 million since the Company started operations in 2020.

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present company overviews at the following conferences.

Jnana Therapeutics today announced that management will participate in the following upcoming investor conferences.

SpectraWAVE, Inc today announced Food and Drug Administration (FDA) 510(k) clearance of their flagship intravascular imaging system, HyperVue™.

Bausch Health Companies Inc. (TSX:BHC)(NYSE:BHC) today announced that Richard De Schutter and Dr. Argeris Karabelas are retiring from the Company’s Board of Directors, effective as of the upcoming 2023 annual meeting of shareholders of the Company.

Celcuity Inc today announced its participation in Cowen’s 43rd Annual Health Care Conference to be held in Boston on March 6-8, 2023.